Company Profile For OraSure Technologies, Inc.

OraSure Technologies, Inc. (OSUR.O) (Nasdaq)
sector: Healthcare · industry: Biotechnology ·
As of  27 Nov 2009
3.94USD
Price Change
-0.16
Percent Change
-3.90%
 
 
Research a stock:   symbol lookup

Overview

Orasure Technologies, Inc. develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its own oral fluid technologies, as well as diagnostic products, including immunoassays and other in vitro diagnostic tests and other medical services. The Company’s diagnostic products include tests, which are processed in a laboratory. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physician’s offices, and commercial and industrial entities.

Quick Financial Synopsis

BRIEF: For the six months ended 30 June 2009, OraSure Technologies, Inc.'s revenues fell 7% to $34.5M. Net loss totaled $6.8M, up from $242K. Revenues reflect lower sales from cryosurgical systems, substance abuse testing products and licensing & product development revenues. Net loss reflects an increase in general & administrative expenses, higher sales & marketing expenses and the presense of impairment of patent & product rights.

Company Address

OraSure Technologies, Inc.
220 East First Street
Bethlehem   PA   18015
P: +1610.8821820
F: +1610.8142937

Total Employees

287

Find Out More About OSUR.O

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement